Curaleaf Holdings Files 6-K Report

Ticker: CURLF · Form: 6-K · Filed: 2025-09-26T00:00:00.000Z

Sentiment: neutral

Topics: regulatory-filing, 6-K, foreign-private-issuer

TL;DR

Curaleaf Holdings filed a 6-K, confirming 40-F annual reports and signed by legal chief.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on September 26, 2025, reporting for the month of September 2025. The filing indicates that Curaleaf is a foreign private issuer and will file annual reports under Form 40-F. The report was signed by Peter Clateman, Chief Legal Officer, on September 25, 2025.

Why It Matters

This filing provides an update on Curaleaf's reporting status as a foreign private issuer, which is relevant for investors tracking regulatory compliance and financial reporting methods.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (6-K) that does not contain new financial or operational information.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the registrant makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.

What does it mean that Curaleaf Holdings, Inc. files under Form 40-F?

Filing under Form 40-F indicates that Curaleaf Holdings, Inc. is a Canadian company and is electing to use this form for its annual reports, which is an alternative to Form 20-F for certain foreign private issuers.

Who signed the Form 6-K filing on behalf of Curaleaf Holdings, Inc.?

The Form 6-K filing was signed by Peter Clateman, Chief Legal Officer, on September 25, 2025.

What is the principal executive office address for Curaleaf Holdings, Inc. as listed in the filing?

The principal executive office address listed is 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada.

What is the filing date of this Form 6-K report?

This Form 6-K report was filed on September 26, 2025.

From the Filing

0001756770-25-000033.txt : 20250926 0001756770-25-000033.hdr.sgml : 20250926 20250926133603 ACCESSION NUMBER: 0001756770-25-000033 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20250925 FILED AS OF DATE: 20250926 DATE AS OF CHANGE: 20250926 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 251348903 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 a6-kcover09252025q3earning.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2025 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: September 25, 2025 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release EX-99.1 2 a2025-09x25xcuraleafxtox.htm EX-99.1 a2025-09x25xcuraleafxtox Curaleaf Holdings, Inc. Investor Relations Curaleaf to Report Third Quarter 2025 Financial and Operational Results STAMFORD, Conn., Sept. 25, 2025 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the third quarter ended September 30, 2025 after market close on November 5, 2025. Management will host a conference call and audio webcast that afternoon at 5:00 p.m. ET consisting of prepared remarks followed by a question-and-answer session related to the Company's operational and financial highlights. Event: Curaleaf Third Quarter 2025 Financial Earnings Conference Call Date: Wednesday, November 5, 2025 Time: 5:00 p.m. ET Live Call: +1-844-512-2926 (U.S.), +1-416-639-5883 (Canada) or +1-412-317-6300 (International) Passcode: 5064695 Webcast: https://ir.curaleaf.com/events For interested individuals unable to join the conference call, a dial-in replay of the call will be available until November 12, 2025, and can be accessed by dialing +1-877-344-7529 (U.S.), +1-855-669-9658 (Canada) or +1-412-317-0088 (International) and entering replay pin number: 8603366 About Curaleaf Holdings Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Anthem and The Hemp Company provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the s

View on Read The Filing